Herve R. Bonnefoi

机构：Goethe University Frankfurt, Université de Bordeaux, Inserm, Heidelberg University, University Hospital Heidelberg, Bordeaux Population Health, European Organisation for Research and Treatment of Cancer, Institut Bergonié, UniCancer Group, NSABP Foundation, BoRdeaux Institute of onCology · ORCID：0000-0003-4293-9748

发表论文 304 篇 · 总被引 25457 次 · h-index 55

代表论文

• Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 (2023 · Annals of Oncology · 被引 242)
• Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer (2025 · New England Journal of Medicine · 被引 147)
• Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer (2023 · Journal of Clinical Oncology · 被引 102)
• Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update (2024 · Journal of Clinical Oncology · 被引 37)
• Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial (2023 · Nature Communications · 被引 31)
• Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025 · Cancer Cell · 被引 27)